Alfresa Holdings Corp <2784.T>-2008/09 group

May 12 (Reuters) -

ALFRESA HOLDINGS CORP

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 1.93 trln 1.77 trln 2.01 trln 985.00

(+9.3 pct) (+11.3 pct) (+3.6%) (+4.0%)
Operating 8.78 25.35 12.00 3.30

(-65.4 pct) (+15.3 pct) (+36.6%) (-55.4%)
Recurring 15.99 31.97 19.30 6.85

(-50.0 pct) (+15.9 pct) (+20.7%) (-36.5%)
Net 5.57 16.18 9.20 2.90

(-65.6 pct) (+35.5 pct) (+65.3%) (-40.1%)
EPS Y133.28 Y396.49 Y220.30 Y69.44
Annual div Y87.00 Y83.00 Y88.00
-Q2 div Y45.00 Y41.00 Y44.00
-Q4 div Y42.00 Y42.00 Y44.00

NOTE - Alfresa Holdings Corp was created in September 2003 by integrating operations of drug wholesalers Fukujin and Azwell.

For latest earnings estimates made by Toyo Keizai, please
double click on 2784.TK1.